Bleomycin A5 plus dexamethasone for control of growth in infantile parotid hemangiomas

Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology and Endodontology

Volumn 108, Issue 1, 2009, Pages 62-69

  Yang, Yaowu ^a   Sun, Moyi ^a   Cheng, Xiaobing ^a   Hu, Xiaoguang ^a   Zhang, Pu ^a   Ma, Qin ^a   Li, Jianhu ^a   Tian, Lei ^a   Lei, Delin ^a  

^a FOURTH MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; ANTINEOPLASTIC ANTIBIOTIC; ANTINEOPLASTIC HORMONE AGONISTS AND ANTAGONISTS; BLEOMYCIN; BLEOMYCIN A5; CONTRAST MEDIUM; DEXAMETHASONE; DIAGNOSTIC AGENT; DRUG DERIVATIVE; GADOLINIUM PENTETATE;

ARTICLE; DOPPLER FLOWMETRY; FEMALE; FOLLOW UP; HEMANGIOMA; HUMAN; INFANT; INTRALESIONAL DRUG ADMINISTRATION; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PAROTID GLAND TUMOR; PHOTOGRAPHY; PHYSICAL EXAMINATION; REMISSION; TREATMENT OUTCOME;

ANTIBIOTICS, ANTINEOPLASTIC; ANTINEOPLASTIC AGENTS, HORMONAL; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BLEOMYCIN; CONTRAST MEDIA; DEXAMETHASONE; FEMALE; FOLLOW-UP STUDIES; GADOLINIUM DTPA; HEMANGIOMA; HUMANS; INFANT; INJECTIONS, INTRALESIONAL; MAGNETIC RESONANCE IMAGING; MALE; PAROTID NEOPLASMS; PHOTOGRAPHY; PHYSICAL EXAMINATION; REMISSION INDUCTION; TREATMENT OUTCOME; ULTRASONOGRAPHY, DOPPLER;

EID: 67649427867     PISSN: 10792104     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tripleo.2009.02.022     Document Type: Article

References (30)

1. Mulliken J.B., and Glowacki J. Hemangiomas and vascular malformations in infants and children: a classification based on endothelial characteristics. Plast Reconstr Surg 69 (1982) 412-420
2. Batsakis J.G. Vascular tumors of the salivary glands. Ann Otol Rhino1 Laryngol 95 (1986) 649-650
3. Ethunandan M., and Mellor T.K. Haemangiomas and vascular malformations of the maxillofacial region-a review. Br J Oral Maxillofac Surg 44 (2006) 263-272
4. Buckmiller L.M., Francis C.L., and Glade R.S. Intralesional steroid injection for proliferative parotid hemangiomas. Int J Pediatr Otorhinolaryngol 72 (2008) 81-87
5. Greene A.K., Rogers G.F., and Mulliken J.B. Management of parotid hemangioma in 100 children. Plast Reconstr Surg 113 (2004) 53-60
6. Reinisch J.F., Kim R.Y., Harshbarger R.J., and Meara J.G. Surgical management of parotid hemangioma. Plast Reconstr Surg 113 (2004) 1940-1948
7. Yang Y., Sun M., Hou R., Yan Z., Wang L., Cheng X., Lei D., and Liu Y. Preliminary study of fibrin glue combined with pingyangmycin for the treatment of venous malformations in the oral and maxillofacial region. J Oral Maxillofac Surg 66 (2008) 2219-2225
8. Zhong P.Q., Zhi F.X., Li R., Xue J.L., and Shu G.Y. Long-term results of intratumorous bleomycin-A5 injection for head and neck lymphangioma. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 86 (1998) 139-144
9. Zhi K., Wen Y., Li L., and Ren W. The role of intralesional pingyangmycin in the treatment of venous malformation of facial and maxillary region. Int J Pediatr Otorhinolaryngol 72 (2008) 593-597
10. Chen Y., Li Y., Zhu Q., Zeng Q., Zhao J., He X., et al. Fluoroscopic intralesional injection with pingyangmycin lipiodol emulsion for the treatment of orbital venous malformations. AJR Am J Roentgenol 190 (2008) 966-971
11. Adams D.M., and Lucky A.W. Cervicofacial vascular anomalies. I. Hemangiomas and other benign vascular tumors. Semin Pediatr Surg 15 (2006) 124-132
12. Thompson L.D.R. Hemangioma of the parotid. Ear Nose Throat J 81 (2002) 769
13. Childers E.L., Furlong M.A., and Fanburg-Smith J.C. Hemangioma of the salivary gland: a study of ten cases of a rarely biopsied/excised lesion. Ann Diagn Pathol 6 (2002) 339-344
14. North P.E., Waner M., Mizeracki A., and Mihm Jr. M.C. GLUT-1: a newly discovered immunohistochemical marker for juvenile heangiomas. Hum Pathol 31 (2000) 11-22
15. Urban P., Philipp C.M., Poetke M., and Berlien H.P. Value of colour coded duplex sonography in the assessment of haemangiomas and vascular malformations. Med Laser Appl 20 (2005) 267-278
16. Yonetsu K., Nakayama E., Miwa K., Tanaka T., Araki K., Kanda S., et al. Magnetic resonance imaging of oral and maxillofacial angiomas. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 76 (1993) 783-789
17. Kakimoto N., Tanimoto K., Nishiyama H., Murakami S., Furukawa S., and Kreiborg S. CT and MR imaging features of oral and maxillofacial hemangioma and vascular malformation. Eur J Radiol 55 (2005) 108-112
18. Yonetsu K., Nakayama E., Kawazu T., Kanda S., Ozeki S., and Shinohara M. Value of contrast-enhanced magnetic resonance imaging in differentiation of hemangiomas from lymphangiomas in the oral and maxillofacial region. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 88 (1999) 496-500
19. Boon L.M., MacdDonald D.M., and Mulliken J.B. Complications of systemic corticosteroid therapy for problematic hemangiomas. Plast Reconstr Surg 104 (1999) 1616-1623
20. Robertson J.S., Wiegand D.A., and Schaitkin B.M. Life-threatening hemangioma arising from the parotid gland. Otolaryngol Head Neck Surg 104 (1991) 858-862
21. Esposito C., Zupi A., and Califano L. Surgical therapy of parotid hemangiomas. Pediatr Surg Int 17 (2001) 335-337
22. Blei F., Isakoff M., and Deb G. The response of parotid hemangiomas to the use of systemic interferon alfa-2a or corticosteroids. Arch Otolaryngol Head Neck Surg 123 (1997) 841-844
23. Mulliken J.B., Rogers G.F., and Marler J.J. Circular excision of hemangioma and purse-string closure: the smallest possible scar. Plast Reconstr Surg 109 (2002) 1544-1554
24. Sarihan H., Mocan H., Yildiz K., Abes M., and Akyazici R. A new treatment with bleomycin for complicated cutaneous hemangioma in children. Eur J Pediatr Surg 7 (1997) 158-162
25. Pienaar C., Graham R., Geldenhuys S., and Hudson D.A. Intralesional bleomycin for the treatment of hemangiomas. Plast Reconstr Surg 117 (2006) 221-226
26. Omidvari S., Nezakatgoo N., Ahmadloo N., Mohammadianpanah M., and Mosalaei A. Role of intralesional bleomycin in the treatment of complicated hemangiomas: prospective clinical study. Dermatol Surg 31 (2005) 499-501
27. Umezawa H. Recent study on biochemistry and action of bleomycin. In: Carter S.K., Crook S.T., and Umezawa H. (Eds). Bleomycin: current status and new development (1978), Academic Press, New York 15-20
28. Zhao J.H., Zhao Y.F., Chen X.M., Zheng X., and Zhang W.F. Histological investigation of veins and venous malformations after injection of sclerosing agents. Asian J Oral Maxillofac Surg 14 (2002) 226-231
29. Zhao F.Y. The efficacy and side effects of the preoperative administration of pingyangmycin in squamous cell carcinoma of the oro-maxillo-facial region. Zhonghua Kou Qiang Ke Za Zhi 20 (1985) 150-153
30. Lam M.S. The need for routine bleomycin test dosing in the 21st century. Ann Pharmacother 39 (2005) 1897-1902